Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study ; day:17 ; month:1 ; year:2024 ; pages:1-10
Journal of neurology ; (17.1.2024), 1-10
- Creator
-
Barbanti, Piero
Aurilia, Cinzia
Egeo, Gabriella
Proietti, Stefania
D’Onofrio, Florindo
Torelli, Paola
Aguggia, Marco
Bertuzzo, Davide
Finocchi, Cinzia
Trimboli, Michele
Cevoli, Sabina
Fiorentini, Giulia
Orlando, Bianca
Zucco, Maurizio
Clemente, Laura Di
Cetta, Ilaria
Colombo, Bruno
Poggio, Monica Laura Bandettini di
Favoni, Valentina
Grazzi, Licia
Salerno, Antonio
Carnevale, Antonio
Robotti, Micaela
Frediani, Fabio
Altamura, Claudia
Filippi, Massimo
Vernieri, Fabrizio
Bonassi, Stefano
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-023-12103-4
- URN
-
urn:nbn:de:101:1-2024032915470835841121
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Barbanti, Piero
- Aurilia, Cinzia
- Egeo, Gabriella
- Proietti, Stefania
- D’Onofrio, Florindo
- Torelli, Paola
- Aguggia, Marco
- Bertuzzo, Davide
- Finocchi, Cinzia
- Trimboli, Michele
- Cevoli, Sabina
- Fiorentini, Giulia
- Orlando, Bianca
- Zucco, Maurizio
- Clemente, Laura Di
- Cetta, Ilaria
- Colombo, Bruno
- Poggio, Monica Laura Bandettini di
- Favoni, Valentina
- Grazzi, Licia
- Salerno, Antonio
- Carnevale, Antonio
- Robotti, Micaela
- Frediani, Fabio
- Altamura, Claudia
- Filippi, Massimo
- Vernieri, Fabrizio
- Bonassi, Stefano
- SpringerLink (Online service)
Other Objects (12)
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Monoclonal Antibodies Targeting CGRP to Treat Vestibular Migraine: A Rapid Systematic Review and Meta-Analysis
Monoclonal antibodies for migraine: an update
Inflammatory complications of CGRP monoclonal antibodies: a case series
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Monoclonal Antibodies Targeting CGRP to Treat Vestibular Migraine: A Rapid Systematic Review and Meta-Analysis
Monoclonal antibodies for migraine: an update
Inflammatory complications of CGRP monoclonal antibodies: a case series
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Monoclonal Antibodies Targeting CGRP to Treat Vestibular Migraine: A Rapid Systematic Review and Meta-Analysis
Monoclonal antibodies for migraine: an update
Inflammatory complications of CGRP monoclonal antibodies: a case series